Poland· PL-100526001
Zurzuvae
A other antidepressants product containing zuranolonum, registered in Poland by Biogen Netherlands B.V.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Zuranolonum is registered in 4 of 19 countries.
Countries holding a registration under ATC N06AX (other antidepressants), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Zuranolonum · ATC N06AX
4 / 19 countries
- Belgiumprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Zuranolonum
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Poland (PL)
- ATC code
- N06AX
- ATC class
- Other antidepressants
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zuranolonum in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZURZUVAEBiogen Netherlands B.V., Badhoevedorp
- United StatesZURZUVAEBiogen MA Inc.
- IrelandZurzuvae 20 mg hard capsulesBiogen Netherlands B.V.
- BelgiumZurzuvae 20 mgBiogen Netherlands
- NetherlandsZurzuvae 20 mg harde capsulesBiogen Netherlands B.V.
- SwedenZurzuvae 20 mg Kapsel, hårdBiogen Netherlands B.V.
- IcelandZurzuvaeBiogen Netherlands B.V.
- FinlandZurzuvaeBiogen Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zurzuvae
- Liechtenstein · Zurzuvae
- Norway · Zurzuvae
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce16ee0d-eb21-4a29-8bfc-97f6c733c163 GET /v1/drugs/ce16ee0d-eb21-4a29-8bfc-97f6c733c163?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "20 mg",
"packaging": "Rp ¦ EU/1/25/1977/001 ¦ 164017\n14 kaps.\nRp ¦ EU/1/25/1977/002 ¦ 164018\n28 kaps. w butelce\nRp ¦ EU/1/25/1977/003 ¦ 164019\n28 kaps. w blistrze",
"substance": "Zuranolonum 20 mg",
"common_name": "Zuranolonum",
"pl_product_id": "100526001",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about zuranolonum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.